| Literature DB >> 26184262 |
Lei Liu1, Jingyang Wu2, Song Yue3, Jin Geng4, Jie Lian5, Weiping Teng6, Desheng Huang7, Lei Chen8,9.
Abstract
A prospective study was carried out from August 2010 to August 2014 in the community of Fengyutan (China). Six hundred and twenty two T2D subjects were collected. The incidence density of diabetic retinopathy (DR) was 1.81% person-year (95% confidence interval, CI: 1.21-2.43% person-year). After a Cox regression model analysis and adjusted confounding factors, independent predictors related to the incidence of DR including male gender (adjusted hazard ratios, aHR: 1.47, 95% CI: 1.21-1.62), with hypertension (aHR: 1.49, 95%: 1.12-1.73), duration of diabetes > 10 years (aHR: 2.28, 95%: 2.05-2.42), uncontrolled diabetes (aHR: 1.76, 95%: 1.41-2.01), total cholesterol ≥ 200 mg/dL (aHR: 1.54, 95%: 1.34-1.72) and HbA1c ≥ 7% (mmol/mol) (aHR: 2.12, 95%: 1.87-2.32). Duration of T2D revealed the significantly dose-response relationship to the onset of DR. The incidence density of DR in the Chinese community was relatively low in comparison with other studies. More attention should be paid to the T2D patients, especially of male gender, with hypertension, longer duration of diabetes, uncontrolled diabetes, total cholesterol ≥ 200mg/dL and HbA1c ≥ 7% (mmol/mol).Entities:
Keywords: community; diabetic retinopathy; epidemiology; incidence density; risk factors
Mesh:
Substances:
Year: 2015 PMID: 26184262 PMCID: PMC4515698 DOI: 10.3390/ijerph120707899
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Number of survival person-year using life table analysis for DR.
| Year | No. of subjects at the beginning of the year | No. of subjects attending into the study during the year | Incidence DR during the year | Subjects without follow-up during the year | Incidence (person-year) |
|---|---|---|---|---|---|
| 2010 | 548 | 40 | 9 | 20 | 548 |
| 2011 | 559 | 55 | 10 | 30 | 559 |
| 2012 | 574 | 50 | 8 | 35 | 574 |
| 2013 | 581 | 35 | 11 | 10 | 581 |
| 2014 | 595 | 20 | 14 | 9 | 595 |
Abbreviation: DR, diabetic retinopathy.
Characteristics of participants in the cohort study, 2010 to 2014.
| Characteristics | Diabetes (n = 622) | DR (n = 52) |
|
|---|---|---|---|
| Age (years) | 69 ± 5.87 | 72 ± 4.11 | < 0.01 |
| Sex, male | 48.98 | 51.92 | < 0.01 |
| Duration of diabetes (years) | 5.04 ± 1.11 | 7.11 ± 2.01 | < 0.01 |
| With hypertension history | 40.11 | 60.41 | < 0.01 |
| With family history of diabetes | 20.12 | 42.35 | < 0.01 |
| Control diabetes | 21.25 | 13.55 | < 0.01 |
| Systolic BP, mmHg | 122.9 ± 17.6 | 139.1 ± 17.4 | < 0.01 |
| Diastolic BP, mmHg | 78.1 ± 10.5 | 87.1 ± 10.4 | < 0.01 |
| Total cholesterol, mg/dL | 188.3 ± 41.1 | 194.2 ± 35.7 | < 0.01 |
| Triglyceride, mg/dL | 177.4 ± 101.3 | 147.5 ± 140.7 | < 0.01 |
| BMI (kg/m2) | 23.8 ± 3.2 | 24.9 ± 3.1 | < 0.01 |
| HbA1c (% (mmol/mol)) | 5.8 ± 0.4 | 7.4 ± 1.4 | < 0.01 |
| FPG, mg/dL | 92.5 ± 9.6 | 151.2 ± 45.5 | < 0.01 |
Data are means ± SDs or frequency (%). Abbreviation: FPG: Fasting plasma glucose; BMI: Body mass index; HbA1c: Glycated hemoglobina1c; DR, diabetic retinopathy.
Hazard ratios of the factors associated with onset of DR.
| Variable | HR | HR 95%CI |
|
|---|---|---|---|
| Age (years) | |||
| < 70 | 1 | ||
| ≥ 70 | 1.36 | 0.97–1.56 | < 0.01 |
| Gender | |||
| Female | 1 | ||
| Male | 1.79 | 1.31–2.32 | < 0.01 |
| Hypertension | |||
| Without | 1 | ||
| With | 1.39 | 1.01–1.62 | < 0.01 |
| Duration of diabetes (years) | |||
| < 5 | 1 | ||
| 5–10 | 1.76 | 1.34–2.20 | < 0.01 |
| > 10 | 1.98 | 1.45–2.31 | < 0.01 |
| Family history of diabetes | |||
| Without | 1 | ||
| With | 1.19 | 0.78–1.31 | 0.06 |
| Controlled diabetes | |||
| Yes | 1 | ||
| No | 1.67 | 1.32–2.13 | < 0.01 |
| Systolic BP, mmHg | |||
| < 140 | 1 | ||
| ≥ 140 | 1.14 | 0.78–1.42 | 0.08 |
| Diastolic BP, mmHg | |||
| < 90 | 1 | ||
| ≥ 90 | 1.04 | 0.88–1.21 | 0.22 |
| BMI (kg/m2) | |||
| < 25 | 1 | ||
| 25–27.4 | 1.08 | 0.88–1.32 | 0.26 |
| > 27.4 | 1.19 | 1.08–1.24 | 0.03 |
| FPG, mg/dL | |||
| < 110 | 1 | ||
| 110–200 | 1.12 | 0.85–1.32 | 0.11 |
| > 200 | 1.92 | 1.75–2.31 | < 0.01 |
| Total cholesterol, mg/dL | |||
| < 200 | 1 | ||
| ≥ 200 | 1.38 | 1.17–1.68 | < 0.01 |
| Triglyceride, mg/dL | |||
| < 150 | 1 | ||
| ≥ 150 | 1.11 | 0.87–1.28 | 0.16 |
| HbA1c (% (mmol/mol)) | |||
| < 7 | 1 | ||
| ≥ 7 | 1.77 | 1.57–2.36 | < 0.01 |
Abbreviation: CI: Confidence interval. FPG: Fasting plasma glucose; BMI: Body mass index; HbA1c: Glycated hemoglobina1c; DR, diabetic retinopathy.
Adjusted hazard ratios of the factors associated with onset of DR.
| Variable | aHR | HR 95%CI |
|
|---|---|---|---|
| Male gender | 1.47 | 1.21–1.62 | < 0.01 |
| With hypertension | 1.49 | 1.12–1.73 | < 0.01 |
| Duration of diabetes (years)* | |||
| 5–10 | 1.86 | 1.53–2.01 | < 0.01 |
| > 10 | 2.28 | 2.05–2.42 | < 0.01 |
| Uncontrolled diabetes | 1.76 | 1.41–2.01 | < 0.01 |
| Total cholesterol, mg/dL ≥ 200 | 1.54 | 1.34–1.72 | < 0.01 |
| HbA1c (%) ≥ 7 | 2.12 | 1.87–2.32 | < 0.01 |
*Duration of diabetes revealed the significantly dose-response relationship to the onset of DR (X2-test for trend = 8.89, p < 0.05) after controlling for other factors.